OGN vs TLS · P/E 3.4, rev $3.02B vs rev $95.5M
Organon & Co (OGN) versus Telos Corp (TLS) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Telos Corp (TLS) is a software - infrastructure company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported TLS revenue for 2026-06-30 was $95.5M. Net income was $2.7M. TLS currently screens at market cap $327.0M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. TLS currently screens at market cap $327.0M.
Not investment advice. Open the OGN and TLS stock pages for the full models.
Not investment advice.